Prostate Cancer - Results from #26920

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy - Abstract October 18, 2011

Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: Assessment of response to hypofractionated robotic stereotactic body radiation therapy - Abstract October 18, 2011

External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy - Abstract October 18, 2011

Adjuvant radiotherapy for a prostate cancer after renal transplantation and review of the literature - Abstract October 18, 2011

A patient with spinal and bulbar muscular atrophy whose high stage and high Gleason score prostate cancer responded to maximal androgen blockade therapy - Abstract October 18, 2011

The long-term outcomes after radical prostatectomy of patients with pathologic Gleason 8-10 disease - Abstract October 18, 2011

Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer - Abstract October 17, 2011

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer - Abstract October 17, 2011

Comorbidities, treatment and ensuing survival in men with prostate cancer - Abstract October 17, 2011

A chemically induced vaccine strategy for prostate cancer - Abstract October 17, 2011

Dimethyl sulfoxide-sodium bicarbonate infusion for palliative care and pain relief in patients with metastatic prostate cancer - Abstract October 17, 2011

Immunotherapy of prostate cancer: Identification of new treatments and targets for therapy, and role of WAP domain-containing proteins - Abstract October 17, 2011

Matched-pair analysis and dosimetric variations of two types of software for interstitial permanent brachytherapy for prostate cancer - Abstract October 17, 2011

Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer - Abstract October 17, 2011

Urethra low-dose tunnels: Validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy - Abstract October 17, 2011

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy - Abstract October 14, 2011

New drugs for prostate cancer - Abstract October 14, 2011

Compliance with biopsy recommendations of a prostate cancer risk calculator - Abstract October 14, 2011

Optimization of PSA screening policies: A comparison of the patient and societal perspectives - Abstract October 14, 2011

Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: Can the change in prostate-specific antigen reliably guide prostate biopsy decisions? - Abstract October 14, 2011

Page 1347 of 1435